
Matwings Technology
Leveraging its independently developed general AI for protein design, AccelProtein.
Date | Investors | Amount | Round |
---|---|---|---|
investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
* | CNY100m | Series A | |
Total Funding | 000k |
Related Content
Matwings
Matwings, founded in 2021 by an elite team from Shanghai Jiao Tong University, is a leading provider of AI-based protein design services in the world.
Leveraging its independently developed general AI for protein design, AccelProtein™, Matwings has addressed the core issues such as long design cycles, high costs, low success rates, and the challenges of multi-objective optimization faced by the traditional paradigm of "expert experience & extensive trial-and-error". The company has played a significant role in enhancing product performance, shortening R & D cycles, reducing production costs, and establishing robust patent portfolios for clients.
In just over two years, Matwings has successfully delivered more than 30 protein design projects, earning recognition from dozens of leading clients in this industry and establishing close and long-term strategic partnerships with numerous upstream and downstream enterprises. Currently, the company's technical services have expanded into multiple fields, including innovative biologics, in vitro diagnostics, pharmaceutical intermediates, nutrition and healthcare, food and beverages, beauty and skincare, textile cleaning, bioenergy, bio-agriculture, and environmental engineering, which demonstrates its extensive influence and technical strength in the field of protein design.